These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25900275)

  • 1. Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.
    Didic M; Felician O; Gour N; Bernard R; Pécheux C; Mundler O; Ceccaldi M; Guedj E
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1512-21. PubMed ID: 25900275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers.
    Yao Z; Hu B; Zheng J; Zheng W; Chen X; Gao X; Xie Y; Fang L;
    PLoS One; 2015; 10(7):e0132300. PubMed ID: 26161964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
    Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
    Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
    Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
    Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN
    J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism and gray-matter concentration in apolipoprotein E ε4 positive normal subjects.
    Samuraki M; Matsunari I; Chen WP; Shima K; Yanase D; Takeda N; Matsuda H; Yamada M
    Neurobiol Aging; 2012 Oct; 33(10):2321-3. PubMed ID: 22188720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
    Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
    Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
    Mosconi L; Perani D; Sorbi S; Herholz K; Nacmias B; Holthoff V; Salmon E; Baron JC; De Cristofaro MT; Padovani A; Borroni B; Franceschi M; Bracco L; Pupi A
    Neurology; 2004 Dec; 63(12):2332-40. PubMed ID: 15623696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
    Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease.
    Quevenco FC; Preti MG; van Bergen JM; Hua J; Wyss M; Li X; Schreiner SJ; Steininger SC; Meyer R; Meier IB; Brickman AM; Leh SE; Gietl AF; Buck A; Nitsch RM; Pruessmann KP; van Zijl PC; Hock C; Van De Ville D; Unschuld PG
    Alzheimers Res Ther; 2017 Mar; 9(1):24. PubMed ID: 28359293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional neuroanatomical associations of working memory in early-onset Alzheimer's disease.
    Kobylecki C; Haense C; Harris JM; Stopford CL; Segobin SH; Jones M; Richardson AMT; Gerhard A; Anton-Rodriguez J; Thompson JC; Herholz K; Snowden JS
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):176-184. PubMed ID: 28299814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
    Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
    Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.